https://bit.ly/4iWji6P
https://bit.ly/4iWji6P
Listen to the latest episode of the Molecular Therapy podcast to learn more about Paloma and her plans for MTNA in the next 5 years:
Listen to the latest episode of the Molecular Therapy podcast to learn more about Paloma and her plans for MTNA in the next 5 years:
ISCT, alongside ASGCT and ARM, has called for a 10-year moratorium on heritable human genome editing to ensure responsible oversight.
📰 Article: buff.ly/wmjf1Nb
📄 Moratorium: buff.ly/9zAXUr4
ISCT, alongside ASGCT and ARM, has called for a 10-year moratorium on heritable human genome editing to ensure responsible oversight.
📰 Article: buff.ly/wmjf1Nb
📄 Moratorium: buff.ly/9zAXUr4
Their pioneering research and clinical leadership continue to drive progress in cell and gene therapy and improve patient outcomes worldwide. We're proud to celebrate this outstanding achievement.
#ASGCT
Explore seven new approvals, an expanding clinical pipeline and the latest advancements shaping the field.
Read more: https://bit.ly/4ufliLp
#ASGCT #CGT
Explore seven new approvals, an expanding clinical pipeline and the latest advancements shaping the field.
Read more: https://bit.ly/4ufliLp
#ASGCT #CGT
- 2 recent publications
- Links to our "Meet the Expert" webinar series recordings
- Upcoming SCGE researcher presentations at ASGCT Breakthroughs
www.linkedin.com/pulse/scge-s...
- 2 recent publications
- Links to our "Meet the Expert" webinar series recordings
- Upcoming SCGE researcher presentations at ASGCT Breakthroughs
www.linkedin.com/pulse/scge-s...
Gain practical insights from clinical and translational experts and earn CME credit.
🔗 https://bit.ly/4uK4PPz
Gain practical insights from clinical and translational experts and earn CME credit.
🔗 https://bit.ly/4uK4PPz
Watch it here today: http://dlvr.it/TVmhly
#AI #MachineLearning #RNA #ASGCT
Watch it here today: http://dlvr.it/TVmhly
#AI #MachineLearning #RNA #ASGCT
Not a member? It's the perfect time to join. https://bit.ly/4yvcuUq
Not a member? It's the perfect time to join. https://bit.ly/4yvcuUq
#RareDisease #GeneTherapy #CellTherapy #ASGCT
#RareDisease #GeneTherapy #CellTherapy #ASGCT
Listen here: http://dlvr.it/TVlHDs
#LentiviralVector #ExVivo
Listen here: http://dlvr.it/TVlHDs
#LentiviralVector #ExVivo
Learn more about the fellowship, eligibility criteria and application deadlines: https://bit.ly/4hciETk
Learn more about the fellowship, eligibility criteria and application deadlines: https://bit.ly/4hciETk
#NORDSummit #RareDisease
#NORDSummit #RareDisease
Join us for this exciting FREE webinar today: http://dlvr.it/TVcMM4
#ArtificialIntelligence #GeneTherapy #RNAtherapeutics #ASGCT
Join us for this exciting FREE webinar today: http://dlvr.it/TVcMM4
#ArtificialIntelligence #GeneTherapy #RNAtherapeutics #ASGCT
#ChildhoodCancer #Immunotherapy
#ChildhoodCancer #Immunotherapy
Learn more and register here today: http://dlvr.it/TVD1kk
#AI #MachineLearning #ASGCT
Learn more and register here today: http://dlvr.it/TVD1kk
#AI #MachineLearning #ASGCT
Save the date, October 21 at 11 AM CDT, and register today: http://dlvr.it/TV8VrM
#RareDisease #ASGCT
Save the date, October 21 at 11 AM CDT, and register today: http://dlvr.it/TV8VrM
#RareDisease #ASGCT